148 related articles for article (PubMed ID: 27840232)
1. Genome-wide pathway-based association analysis identifies risk pathways associated with Parkinson's disease.
Zhang M; Mu H; Shang Z; Kang K; Lv H; Duan L; Li J; Chen X; Teng Y; Jiang Y; Zhang R
Neuroscience; 2017 Jan; 340():398-410. PubMed ID: 27840232
[TBL] [Abstract][Full Text] [Related]
2. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
[TBL] [Abstract][Full Text] [Related]
3. Genomic convergence of locus-based GWAS meta-analysis identifies AXIN1 as a novel Parkinson's gene.
Saeed M
Immunogenetics; 2018 Sep; 70(9):563-570. PubMed ID: 29923028
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
[TBL] [Abstract][Full Text] [Related]
5. Pathway analysis of genome-wide association studies for Parkinson's disease.
Song GG; Lee YH
Mol Biol Rep; 2013 Mar; 40(3):2599-607. PubMed ID: 23238920
[TBL] [Abstract][Full Text] [Related]
6. The SNP ratio test: pathway analysis of genome-wide association datasets.
O'Dushlaine C; Kenny E; Heron EA; Segurado R; Gill M; Morris DW; Corvin A
Bioinformatics; 2009 Oct; 25(20):2762-3. PubMed ID: 19620097
[TBL] [Abstract][Full Text] [Related]
7. Candidate novel long noncoding RNAs, MicroRNAs and putative drugs for Parkinson's disease using a robust and efficient genome-wide association study.
Mortezaei Z; Lanjanian H; Masoudi-Nejad A
Genomics; 2017 Jul; 109(3-4):158-164. PubMed ID: 28235564
[TBL] [Abstract][Full Text] [Related]
8. The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.
Berge-Seidl V; Pihlstrøm L; Maple-Grødem J; Forsgren L; Linder J; Larsen JP; Tysnes OB; Toft M
Neurosci Lett; 2017 Sep; 658():48-52. PubMed ID: 28830825
[TBL] [Abstract][Full Text] [Related]
9. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease.
Dumitriu A; Golji J; Labadorf AT; Gao B; Beach TG; Myers RH; Longo KA; Latourelle JC
BMC Med Genomics; 2016 Jan; 9():5. PubMed ID: 26793951
[TBL] [Abstract][Full Text] [Related]
10. Investigating the Shared Genetic Etiology Between Parkinson's Disease and Depression.
Reyes-Pérez P; García-Marín LM; Aman AM; Antar T; Flores-Ocampo V; Mitchell BL; Medina-Rivera A; Rentería ME
J Parkinsons Dis; 2024; 14(3):483-493. PubMed ID: 38457145
[TBL] [Abstract][Full Text] [Related]
11. Toward identification of susceptibility genes for sporadic Parkinson's disease.
Toda T; Momose Y; Murata M; Tamiya G; Yamamoto M; Hattori N; Inoko H
J Neurol; 2003 Oct; 250 Suppl 3():III40-3. PubMed ID: 14579123
[TBL] [Abstract][Full Text] [Related]
12. Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
Liu G; Zhang F; Jiang Y; Hu Y; Gong Z; Liu S; Chen X; Jiang Q; Hao J
Mult Scler; 2017 Feb; 23(2):205-212. PubMed ID: 27207450
[TBL] [Abstract][Full Text] [Related]
13. Pathway analysis of two amyotrophic lateral sclerosis GWAS highlights shared genetic signals with Alzheimer's disease and Parkinson's disease.
Shang H; Liu G; Jiang Y; Fu J; Zhang B; Song R; Wang W
Mol Neurobiol; 2015 Feb; 51(1):361-9. PubMed ID: 24647822
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee.
Hamza TH; Chen H; Hill-Burns EM; Rhodes SL; Montimurro J; Kay DM; Tenesa A; Kusel VI; Sheehan P; Eaaswarkhanth M; Yearout D; Samii A; Roberts JW; Agarwal P; Bordelon Y; Park Y; Wang L; Gao J; Vance JM; Kendler KS; Bacanu SA; Scott WK; Ritz B; Nutt J; Factor SA; Zabetian CP; Payami H
PLoS Genet; 2011 Aug; 7(8):e1002237. PubMed ID: 21876681
[TBL] [Abstract][Full Text] [Related]
15. Genes for Parkinson's disease.
Toda T
Nihon Rinsho; 2017 Jan; 75(1):21-27. PubMed ID: 30566290
[TBL] [Abstract][Full Text] [Related]
16. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
Pierce S; Coetzee GA
PLoS One; 2017; 12(4):e0175882. PubMed ID: 28407015
[TBL] [Abstract][Full Text] [Related]
18. Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson's Disease Susceptibility.
Liu G; Liu Y; Jiang Q; Jiang Y; Feng R; Zhang L; Chen Z; Li K; Liu J
Mol Neurobiol; 2016 Sep; 53(7):4931-8. PubMed ID: 26365049
[TBL] [Abstract][Full Text] [Related]
19. Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson's disease.
Glaab E; Schneider R
Neurobiol Dis; 2015 Feb; 74():1-13. PubMed ID: 25447234
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of microarray datasets to identify Parkinson's disease‑associated pathways and genes.
Feng Y; Wang X
Mol Med Rep; 2017 Mar; 15(3):1252-1262. PubMed ID: 28098893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
